IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
This study has been completed.
Sponsor:
Boehringer Ingelheim
Information provided by:
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT00614302
First received: January 31, 2008
Last updated: October 1, 2009
Last verified: October 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Data collection for better patient characterization in a highly treatment experienced population. Studying the clinical practice for the treatment of HIV multiexperienced patients in the real life.
The research will be divided into two phases:
- The first phase intends to define and understand the clinical practice using a questionnaire about general topics: definitions of multiexperienced patients and VL failure, therapeutic strategies and behaviour in particular cases.
- The second part of the research will collect the clinical data of double PIs failure patients.
| Condition | Intervention |
|---|---|
| HIV Infections | Drug: TPV |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Patient Population |
Resource links provided by NLM:
Further study details as provided by Boehringer Ingelheim:
Primary Outcome Measures:
- To study in the clinical practice the choice of a specific salvage regimen for multiexperienced patients. [ Time Frame: 48 weeks ]
Secondary Outcome Measures:
- Reason of each VL failure or switching [ Time Frame: 48 weeks ]
| Enrollment: | 428 |
| Study Start Date: | June 2007 |
| Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
HIV patients
Criteria
Inclusion Criteria:
Patients double PIs failure
Exclusion Criteria:
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00614302
Please refer to this study by its ClinicalTrials.gov identifier: NCT00614302
Locations
| Italy | |
| Boehringer Ingelheim Investigational Site | |
| Ancona, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Bari, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Benevento, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Bisceglie, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Bologna, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Brescia, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Busto, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Caserta, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Catania, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Cremona, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Firenze, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Genova, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Legnano, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Milano, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Napoli, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Padova, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Palermo, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Pavia, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Roma, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Sassari, Italy | |
| Boehringer Ingelheim Investigational Site | |
| Torino, Italy | |
Sponsors and Collaborators
Boehringer Ingelheim
Investigators
| Study Chair: | Boehringer Ingelheim | Boehringer Ingelheim |
More Information
| Responsible Party: | Boehringer Ingelheim, Study Chair, Boehringer Ingelheim |
| ClinicalTrials.gov Identifier: | NCT00614302 History of Changes |
| Other Study ID Numbers: |
1182.130 |
| Study First Received: | January 31, 2008 |
| Last Updated: | October 1, 2009 |
Additional relevant MeSH terms:
|
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |
ClinicalTrials.gov processed this record on June 22, 2017